Literature DB >> 17409339

Transient hypophysitis after cytotoxic T lymphocyte-associated antigen 4 (CTLA4) blockade.

Stephanie A Shaw1, Luis H Camacho, Ian E McCutcheon, Steven G Waguespack.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17409339     DOI： 10.1210/jc.2006-2484

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN： 0021-972X            Impact factor:   5.958


× No keyword cloud information.
  5 in total

Review 1.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

2.  Lymphocytic hypophysitis with diabetes insipidus in a young man.

Authors:  Ole-Petter R Hamnvik; Anna R Laury; Edward R Laws; Ursula B Kaiser
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

Review 3.  Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports.

Authors:  Meng H Tan; Ravi Iyengar; Kara Mizokami-Stout; Sarah Yentz; Mark P MacEachern; Li Yan Shen; Bruce Redman; Roma Gianchandani
Journal:  Clin Diabetes Endocrinol       Date:  2019-01-22

Review 4.  CTLA-4 blockade with ipilimumab: biology, safety, efficacy, and future considerations.

Authors:  Luis H Camacho
Journal:  Cancer Med       Date:  2015-01-25       Impact factor: 4.452

Review 5.  Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis.

Authors:  Anne Bertrand; Marie Kostine; Thomas Barnetche; Marie-Elise Truchetet; Thierry Schaeverbeke
Journal:  BMC Med       Date:  2015-09-04       Impact factor: 8.775
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.